Waverley Pharma (TSXV:WAVE) FCF Yield % : -94.54 (As of May. 21, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Waverley Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Waverley Pharma's Trailing 12-Month Free Cash Flow is C$-1.02 Mil, and Market Cap is C$1.08 Mil. Therefore, Waverley Pharma's FCF Yield % for today is -94.54%.

The historical rank and industry rank for Waverley Pharma's FCF Yield % or its related term are showing as below:

TSXV:WAVE' s FCF Yield % Range Over the Past 10 Years
Min: -94.54 Med: -16.73 Max: -2.25
Current: -94.54

During the past 8 years, the highest FCF Yield % of Waverley Pharma was -2.25%. The lowest was -94.54%. And the median was -16.73%.

TSXV:WAVE's FCF Yield % is ranked worse than
84.45% of 1556 companies
in the Biotechnology industry
Industry Median: -14.055 vs TSXV:WAVE: -94.54

Waverley Pharma's FCF Margin % for the quarter that ended in Dec. 2023 was -983.67%.

Waverley Pharma FCF Yield % Historical Data

The historical data trend for Waverley Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waverley Pharma FCF Yield % Chart

Waverley Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-26.17

-5.36

-18.50

-14.63

-75.63

Waverley Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-46.67	-12.44	-34.63	-79.41	-142.81

Competitive Comparison of Waverley Pharma's FCF Yield %

For the Biotechnology subindustry, Waverley Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Waverley Pharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Waverley Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Waverley Pharma's FCF Yield % falls into.

Waverley Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Waverley Pharma's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-1.021	/	1.35
	=	-75.63%

Waverley Pharma's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.482	*	4	/	1.35
	=	-142.81%

Waverley Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Waverley Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Waverley Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Waverley Pharma (TSXV:WAVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Waverley Pharma Inc (TSXV:WAVE) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

5GZ:Germany

Address

1250 Waverley Street, Suite 4, Winnipeg, MB, CAN, R3T 6C6

Website

https://www.waverleypharma.com

Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Capecitabine and Temozolomide, among others.

Executives

Albert David Friesen

10% Security Holder, Director, Senior Officer